[1]
U. M. Yelisetti, “Curcumin Nanoformulations For Neurological and Psychiatric Disorders: Delivery Strategies, Preclinical Evidence and Translational Prospects”, Adolescência e Saúde, pp. 8–21, Nov. 2026.